Zhenjiang Highsea Biological Pharmaceutical Co., Ltd. (formerly known as Yangzhou Wiseman Abil Pharmaceutical Co., Ltd., established in 1996) is a production and sales enterprise integrating chemical synthesis and new product research and development. It is currently a leading global producer of doxycycline series products. Located in the eastern suburbs of Zhenjiang, a city renowned for its history and culture in China, the company enjoys a superior geographical position with direct access to the Jinghu and Huning Expressways. It covers an area of 65,000 m² with a building area of 12,500 m². In 2016, the company fully passed the ISO 9001, ISO 14000, and ISO 18000 management system certifications, and in January 2017, it obtained the national GMP certification.